Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AdimFlu-S quadrivalent influenza vaccine versus Fluarix Tetra in healthy adults
2016-001557-41Phase 3Completed
- Sponsor
- Adimmune
- Start
- Aug 2016
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in influenza comparing AdimFlu-S with Fluarix Tetra (2 arms). Primary endpoints: Primary immunogenicity endpoint and Primary seroconversion endpoint. Started Aug 2016; status: completed.
02
Drugs
influenza virus vaccine, split virionFluarix Quadrivalent
03
Conditions
influenza
Beyond the preview
Go deeper on 2016-001557-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001557-41.